Three Reasons to Wake Up to Morningstar
-
Font Size:
Superior Free Cash Flow Generation
Much has been written recently about the importance of a company generating adequate free cash flow (click here for a more detailed explanation of Free Cash Flow). All the attention is much warranted. Having the ability to generate excess cash is beneficial as it can be used in many different ways to increase shareholder value. Ways to increase shareholder value include stock buybacks, dividend payments, and even the ability to acquire companies without adding any additional debt.
Think about free cash flow from a personal aspect; wouldn’t it be nice to have extra cash per month from your paycheck after paying all your bills and living costs like groceries? All that excess cash can be used to purchase a new TV or enhance your DVD collection. Historically, many companies don’t have superior Free Cash Flow because they need to invest any cash earned back in the business. Auto makers are a good example. They make a ton of cash but require a lot of cash right back into the business (think factories, engineering.)
Over the past few years, Morningstar has been able to grow and expand its FCF at a nice clip. In 2004, the company reported FCF of $25 million and $93 million in the most recently reported 2006 results. Management has decided to use this excess cash to make a variety of acquisitions that boosted their Investing Consulting business and International presence; both which are keys to future growth. Going forward, it appears the company could grow FCF an annual growth rate of about 15% for the next five years. Odds are the Company will probably use the free cash to fund more acquisitions, especially from an international presence, and buy back some stock.
Strong Business Model
The Company’s main weapon is its vast databases of information on mutual funds, stocks and other investments which it sells to its customers as the basis of its business. Morningstar is the first database business model I have examined. I never realized how strong using databases as the basis of a company’s business model can be. If you think about, creating a database has significant upfront and fixed costs. However, the beauty of the Morningstar model is that once the upfront costs are incurred, adding any additional customers is dirt cheap because they are able to cross sell the heck out of the databases. Without spoiling the last topic of discussion below, the company has been able to successfully cross sell database information into viable specific business segments to increase growth.
For the near future, MORN’s profitability should be relatively high because the company incurred most of the upfront costs of creating their databases already. So adding the additional customers of the past few quarters has been relatively cheap. This trend should continue in the near future, as the company shouldn’t require a great deal of investment in their already strong database. However, don’t expect exploding growth because the company will potentially require investments into the international equities and hedge fund databases.
Strong Business Segments
Prior to researching MORN as a potential investment, my impression of the company was probably similar to many others; the company sells its mutual fund “star ratings” to businesses like Yahoo (YHOO) and MSN (MSFT) to use on their finance branded sites. After further research I noticed that, while this segment was a large part of the company’s revenue, MORN has many other business lines. More specifically, I was impressed with how the company used its dominant position in mutual fund ratings to expand into many different products and business segments. The business segment expansion evidenced in the past gives me confidence that Management will continue to find additional revenue streams in the future. Below is a listing of segment revenue and percentages:
Top Five Products (Segment) 2006*
Investment Consulting (Institutional) $ 46,597 - 14.8 %
Advisor Workstation (Advisor) $43,140 - 13.7%
Licensed Data (Institutional) $37,730 - 12.0%
Morningstar.com (Individual) $31,311 - 9.9%
Principia (Advisor) $28,735 - 9.1%
*Below is a quick overview of each (segment) obtained from 2006 10-K
Individual - which focuses on products and services for individual investors;
Advisor - which focuses on products and services for financial advisors; and
Institutional - which focuses on products and services for institutional clients, including banks, brokerage firms, insurance companies, mutual fund companies, media outlets, and retirement plan providers and sponsors.
The notes above are just a few reasons why I purchased a position in MORN. In reality, there are a number of additional reasons why I purchased shares. I would recommend performing additional analysis to determine if the investment is appropriate for your portfolio.
Disclosure: I own shares Morningstar.
MORN 1-yr chart

Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
-
Editor's Picks
-
Most Popular
- Assurant Is A Compelling Short Sell
- Broadcom Enters FTTH Chipset Market
- Another Macroshares Oil Arbitrage Opportunity
- Freeport McMoran: With Copper Prices Rising, It's Still a Buy
- Oil and the Futures Market
- Three Ways to Cash In on Record Meat and Dairy Prices
- Full list of Editor's Picks »
- High Likelihood of a Market Crash »
- Time To Start Buying Some Dogs? »
- Sirius-XM Combination: A Future Microsoft Acquisition? »
- JP Morgan Offer for Wachovia Makes Sense »
- High-Yield Canadian Royalty Trusts: What's the Catch? »
- Adding to My GE Position »
- 7 Stocks for a High Yield Cash Flow Portfolio »
- Drybulk Shipping: Prepare for a New Record High »
- Nokia: Bargain of a Lifetime - Barron's »
- Top 10 Payout Yield Stocks »
- Wall Street Breakfast: Must-Know News »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Adding Wood to Your Portolio: A Worthwhile Investment
- Arkansas Steel: 10 Structural Changes That Should Trump the Business Cycle
- Gross Margin Drivers at Potash Corp. (Part II)
- A New Strategy for EXACT Sciences
- Cytori Therapeutics: The Stem Cell 'Celution' for Success
- LDK Solar: The Brightest Opportunity?
- Big Lots, Wal-Mart and Costco: 3 Musketeers of the Pooring of America
- What's Behind Hansen's Smackdown?
- The Long Case for China Medical Technologies
- ASA Limited: A Golden Opportunity
- Full list of Long Ideas »
- Crystal River’s Q2 Write-Downs Could Bankrupt the Company
- Assurant Is A Compelling Short Sell
- Fuel Systems Solutions: Time to Take Profits
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Pair Trade Visa and Capital One
- Amazon's Kindle Numbers: All Fluff, Zero Substance
- A. Schulman: Cashless Profits
- Titan Machinery: Doesn't Anybody Look at Valuation?
- Goodrich Petroleum: Gas in the Ground Doesn't Mean Cash in the Bank
- Outlook Remains Grim for MBIA, Ambac
- Full list of Short Ideas »
- StanCorp a Safe Financial - Cramer's Lightning Round (7/2/08)
- Momentum Stocks Stalled - Cramer's Stop Trading! (7/3/08)
- Expecting a Lift for Pediatrix: Cramer's Mad Money (7/3/08)
- The Most Bullish Thing - Cramer's Stop Trading! (7/1/08)
- Exelon's Got Nukes - Cramer's Lightning Round (7/1/08)
- Prescription Prediction for Allscripts - Cramer's Mad Money (7/1/08)
- Rex Marks the Spot - Cramer's Lightning Round, (6/30/08)
- Medicare Bill Buys - Cramer's Mad Money (6/30/08)
- Cracker Bottom of the Barrel - Cramer's Lightning Round (6/27/08)
- Britannia Bulk Rules the Waves - Cramer's Mad Money (6/27/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email



This article has 1 comment:
Jackson